Judy S Wang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Clostridium Difficile

Acute Lymphoblastic Leukemia

Prostate Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Babar Bashir, Judy S Wang, Gerald S Falchook, Elisa Fontana, Hendrick-Tobias Arkenau, Louise Carter, Rachel Galot, Bristi Basu, Alastair P Greystoke, Vivek Subbiah, Debra L Richardson, Hanna Orr, Gavin Bennett, Rajiv Sharma, Hongmei Xu, Paola Paganoni, Cong Xu, Carly Campbell, Meredith A McKean
Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Erika Paige Hamilton, Judy S Wang, Amit M Oza, Manish R Patel, Susanna V Ulahannan, Todd M Bauer, Janet L Karlix, Jorge Zeron-Medina, Giulia Fabbri, Paola Marco-Casanova, Ganesh Moorthy, Maureen M Hattersley, Gillian M Littlewood, Patrick D Mitchell, Jamal Saeh, Gayle P Pouliot, Kathleen M Moore
First-in-Human Study of AZD5153, A Small Molecule Inhibitor of Bromodomain Protein 4, in Patients with Relapsed/Refractory Malignant Solid Tumors and Lymphoma. Molecular cancer therapeutics (2023)
Maria Vieito, Victor Moreno, Anna Spreafico, Irene Brana, Judy S Wang, Meir Preis, Tatiana Hernández, Sofia Genta, Aaron Richard Hansen, Bernard Doger, Vladimir Galvao, Laurie Lenox, Regina J Brown, Anna Kalota, Jaydeep Mehta, Friederike Pastore, Bharvin Patel, Pankaj Mistry, Junchen Gu, Josh D Lauring, Manish R Patel
Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
David S Hong, Kathleen M Moore, Johanna C Bendell, Daniel D Karp, Judy S Wang, Susanna V Ulahannan, Suzanne F Jones, Wenjuan Wu, Gregory P Donoho, Yan Ding, Andrew Capen, Aimee Bence Lin, Manish R Patel
Preclinical Evaluation and Phase Ib Study of Prexasertib, a CHK1 Inhibitor, and Samotolisib (LY3023414), a Dual PI3K/mTOR Inhibitor. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (7) (2021)
Mansoor N Saleh, Manish R Patel, Todd M Bauer, Sanjay Goel, Gerald S Falchook, Geoffrey I Shapiro, Ki Y Chung, Jeffrey R Infante, Robert M Conry, Guilherme Rabinowits, David S Hong, Judy S Wang, Ulrich Steidl, Gurudatta Naik, Vincent Guerlavais, Vojislav Vukovic, D Allen Annis, Manuel Aivado, Funda Meric-Bernstam
Phase 1 Trial of ALRN-6924, a Dual Inhibitor of MDMX and MDM2, in Patients with Solid Tumors and Lymphomas Bearing Wild-Type TP53. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
Johann S de Bono, Mark T Fleming, Judy S Wang, Richard Cathomas, Manuel Selvi Miralles, John Bothos, Mary Jane Hinrichs, Qu Zhang, Peng He, Marna Williams, Anton I Rosenbaum, Meina Liang, Kapil Vashisht, Song Cho, Pablo Martinez, Daniel P Petrylak
Phase I Study of MEDI3726: A Prostate-Specific Membrane Antigen-Targeted Antibody-Drug Conjugate, in Patients with mCRPC after Failure of Abiraterone or Enzalutamide. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (13) (2021)